GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4d pharma PLC (OTCPK:LBPWQ) » Definitions » Inventory-to-Revenue

LBPWQ (4d pharma) Inventory-to-Revenue : 1.02 (As of Dec. 2021)


View and export this data going back to 2021. Start your Free Trial

What is 4d pharma Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. 4d pharma's Average Total Inventories for the quarter that ended in Dec. 2021 was $0.40 Mil. 4d pharma's Revenue for the six months ended in Dec. 2021 was $0.39 Mil. 4d pharma's Inventory-to-Revenue for the quarter that ended in Dec. 2021 was 1.02.

4d pharma's Inventory-to-Revenue for the quarter that ended in Dec. 2021 declined from Jun. 2021 (1.26) to Jun. 2021 (1.02)

A decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year. 4d pharma's Inventory Turnover for the quarter that ended in Dec. 2021 was 0.00.


4d pharma Inventory-to-Revenue Historical Data

The historical data trend for 4d pharma's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4d pharma Inventory-to-Revenue Chart

4d pharma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Inventory-to-Revenue
Get a 7-Day Free Trial - - 1.36 0.55 0.54

4d pharma Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21
Inventory-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.36 0.77 0.94 1.26 1.02

Competitive Comparison of 4d pharma's Inventory-to-Revenue

For the Biotechnology subindustry, 4d pharma's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


4d pharma's Inventory-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 4d pharma's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where 4d pharma's Inventory-to-Revenue falls into.



4d pharma Inventory-to-Revenue Calculation

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

4d pharma's Inventory-to-Revenue for the fiscal year that ended in Dec. 2021 is calculated as

Inventory-to-Revenue (A: Dec. 2021 )
=Average Total Inventories / Revenue
=( (Total Inventories (A: Dec. 2020 ) + Total Inventories (A: Dec. 2021 )) / count ) / Revenue (A: Dec. 2021 )
=( (0.391 + 0.362) / 2 ) / 0.694
=0.3765 / 0.694
=0.54

4d pharma's Inventory-to-Revenue for the quarter that ended in Dec. 2021 is calculated as

Inventory-to-Revenue (Q: Dec. 2021 )
=Average Total Inventories / Revenue
=( (Total Inventories (Q: Jun. 2021 ) + Total Inventories (Q: Dec. 2021 )) / count ) / Revenue (Q: Dec. 2021 )
=( (0.428 + 0.362) / 2 ) / 0.386
=0.395 / 0.386
=1.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


4d pharma  (OTCPK:LBPWQ) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

4d pharma's Days Inventory for the six months ended in Dec. 2021 is calculated as:

Days Inventory=Average Total Inventories (Q: Dec. 2021 )/Cost of Goods Sold (Q: Dec. 2021 )*Days in Period
=0.395/0*365 / 2
=

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

4d pharma's Inventory Turnover for the quarter that ended in Dec. 2021 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Dec. 2021 ) / Average Total Inventories (Q: Dec. 2021 )
=0 / 0.395
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


4d pharma Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of 4d pharma's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


4d pharma Business Description

Traded in Other Exchanges
N/A
Address
9 Bond Court, Fifth Floor, Leeds, GBR, LS1 2JZ
4d pharma PLC and its subsidiaries are in the business of research and development and production of live biotherapeutic products. The company develops biotherapeutic products for diseases such as cancer, asthma, autism, and autoimmune conditions such as arthritis and multiple sclerosis. Its developing science includes Live biotherapeutics, Microbiome, MicroRx, MicroDx, and others.